Tougher FDA Process Hurts Local Bio-Tech Firms
BOSTON (CBS) - The FDA's drug approval process is tougher now and that's bad news for three local bio-tech firms developing new medications.
Lisa van der Pool of the Boston Business Journal reports.
Watch CBS News
BOSTON (CBS) - The FDA's drug approval process is tougher now and that's bad news for three local bio-tech firms developing new medications.
Lisa van der Pool of the Boston Business Journal reports.